[auto-translated] olympus medical systems corp.(omsc) received a literature titled "radiation-free digital cholangioscopy-guided laser lithotripsy for large common bile duct stones: feasibility and technical notes".The study reported the experience of non-radiation endoscopic retrograde cholangiopancreatography (ercp) for large cbd stones using digital cholangioscopy-guided laser lithotripsy.Biliary access was achieved in all patients using standard guidewire-assisted cannulation, double-guidewire technique, and transpancreatic precut in twelve, two, and two patients, respectively.Balloons of 10 mm, 8 mm, and 6 mm in diameter were applied for epbd in 8, 2, and 6 patients, respectively.Complete stone removal in one session was achieved in all patients.One round of laser lithotripsy was needed for stone = 25 mm, and three-to-five rounds were needed for stones > 25 mm or multiple stones.One or two clips were used for endoscopic clipping.The time lengths of biliary access, digital cholangioscopy-assisted laser lithotripsy and stone extraction, and whole procedure were 3.5 ± 3.2 (0.5¿12) minutes, 52.5 ± 30.6 (45¿97) minutes, and 76 ± 23.3 (58¿106) minutes, respectively.Asymptomatic hyperleukocytose, hyperamylasemia, and mild pancreatitis were present in 1, 2, and 1 patient(s), respectively.No other complications occurred.No cholangitis or recurrent cbd stones were observed.Non-radiation digital cholangioscopy-guided laser lithotripsy is technically feasible and can be safely performed for endoscopic management of large cbd stones.Type of adverse events/number of patients.Asymptomatic hyperleukocytose - 1 patient.Hyperamylasemia - 2 patients.Mild post-ercp pancreatitis - 1 patient.Spontaneous biliary stent dislodgement - 4 patients.Since the literature described "tjf-260" but it was not registered, we selected "tjf-260v.".
|
This report is being supplemented to provide a correction and additional information based on the legal manufacturer's final investigation.The serial number of the device was (b)(6), therefore the device history record was reviewed for both devices.All records indicated the product was manufactured according to all applicable procedures and met final product release criteria.No abnormalities were found.H4: manufacturing date of the devices was as below: tjf-260v, sn#(b)(6): 27may2019, tjf-260v, sn#(b)(6): 26dec2017.Based on the results of the investigation, the relationship between the device and the adverse event cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Olympus will continue to monitor field performance for this device.
|